Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review
- 1 September 2021
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (5) , e15048
Abstract
Psoriasis is a systemic inflammatory disease commonly associated with postinflammatory hyper- and hypo-pigmentation. Psoriasis-related cytokines such as IL-17 and TNF can contribute to these pigmentation changes by regulating both the growth and pigment production of melanocytes. Here, we present the first reported the case of a patient with a 10-year history of severe psoriasis vulgaris, who developed multiple lentigines in areas of resolved psoriatic plaques during anti-IL-17A antibody secukinumab.Keywords
This publication has 9 references indexed in Scilit:
- Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature reviewDermatologic Therapy, 2020
- Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticariaClinical & Experimental Allergy, 2020
- Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)Journal of the European Academy of Dermatology and Venereology, 2020
- Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataArthritis Research & Therapy, 2019
- Appearance of lentigines in psoriasis patient treated with guselkumabDermatology Online Journal, 2019
- Multiple lentigines arising on resolving psoriatic plaques after treatment with apremilastClinical and Experimental Dermatology, 2018
- Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literatureCutaneous and Ocular Toxicology, 2014
- Dysregulation of melanocyte function by Th17‐related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgarisPigment Cell & Melanoma Research, 2012
- Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi?British Journal of Dermatology, 2011